上下期目录列表 Journal Of Modern Oncology

[2681-2687] ADAM8 promotes epithelial and mesenchymal transformation in colon cancer by activating the STAT3 signaling pathway

[CAO Saiya¹,LIU Yang¹,TANG Donghao²,LI Yanrong¹,LI Jiaxian¹,WANG Jie^1,2,CHEN Chao¹]

2024 15 [Abstract]()

[2688-2694] miR-34a-5p enhances the sensitivity of cisplatin in cervical cancer cells and its possible mechanism

[JIA Yijuan,LIU Lidan,GONG Shixiong,LI Ling]

2024 15 [Abstract]()

[2695-2703] Effects of sinensetin on the proliferation,apoptosis,and epithelial mesenchymal transition of cervical cancer cells by regulating YAP/TAZ axis

[XIE Xu,ZHANG Xinping,GUO Liping,XU Xin]

2024 15 [Abstract]()

[2703-2715] Circular RNA hsa_circ_0078767 regulates ferroptosis in lung cancer cells through miR-330-3p/p53 axis

[WANG Yinghui¹，JIANG Hua²，LU Lin³，YE Lijuan⁴，HOU Fei¹，PENG Xiaoqi¹，CAI Haolin¹，ZHENG Xihua¹，CHEN Ting¹]

2024 15 [Abstract]()

[2716-2722] lncRNA HOTAIR promotes proliferation,migration and invasion of non-small-cell lung cancer by targeting miR-1

[RUAN Lianjie]

2024 15 [Abstract]()

[2722-2729] Methodological study on the isolation and identification of human breast cancer stem cells based on CD44 and ALDH1

[JIANG Qin¹,ZHANG Manli¹,CHEN Hongqing²,ZHANG Xufan²,LI Sheng¹]

2024 15 [Abstract]()

[2730-2737] Role of GSDME in DADS-induced pyroptosis in leukemic K562 cells

[ZHOU Lingyan,HU Xuanyuan,LIU Yinhua,YIN Xiaocheng]

2024 15 [Abstract]()

[2738-2745] Choline kinase α mediates the malignant phenotype of glioblastoma U87MG cells through exosomes

[LI Jialin,ZOU Yourui,LIU Yang,ZHAO Yang,MA Hui]

2024 15 [Abstract]()

[2746-2752] Basic research on thyroid cancer helps epidemiological screening

[TANG Xiaojia，ZHAO Wenhu，Gesangzhuoga，DENG Liping]

2024 15 [Abstract]()

[2752-2759] Near-infrared fluorescent/indocyanine green imaging combined with carbon nanoparticles in thyroid cancer parathyroid gland identification during total resection

[ZHENG Lu¹,TANG Tong¹,WANG Shuai¹,MENG Lei¹,XU Weimin¹,WANG Zhitao²,CAI Huiming³]

2024 15 [Abstract]()

[2760-2766] Efficacy and prognostic factors analysis on small-cell lung cancer patients with second-line chemotherapy

[LI Zhihua^1,2,LI Zhaoxia¹,CHEN Junnan¹,ZHA Haoran¹,SHEN Wennan¹,DONG Yuemei¹,ZHAO Wei¹,WANG Ning¹,LIU Xiaoqing² ]

2024 15 [Abstract]()

[2767-2776] Analysis of clinicopathological features,treatment and prognosis of breast medullary carcinoma

[TAN Qiao^1,2,SU Xiaohan^1,2,HOU Lingmi^1,2,LI Junyan³]

2024 15 [Abstract]()

[2776-2782] Screening immunotherapy markers and adjuvant drugs for PD-L1 negative patients with non-small cell lung cancer based on network regulation analysis

[KE Yizhong,SHI Lei]

2024 15 [Abstract]()

[2783-2788] The value of mSEPT9 detection in the diagnosis and recurrence monitoring of colorectal cancer

[CHEN Jiaojiao,LI Rong,ZHANG Ke,HU Fengdi,XIE Lin]

2024 15 [Abstract]()

[2788-2795] Selection of immune-related genes and construction of prognosis model for cholangiocarcinoma

[LI Hanqi¹,SHI Yu²,WU Shaobo³,TAO Jie¹,SUN Hao¹,LIU Qingguang¹,SUN Liankang¹]

2024 15 [Abstract]()

[2796-2801] Explore the cutoff value of lateral pelvic lymph node short diameter for preoperative prediction of lateral pelvic lymph node metastasis of rectal cancer based on MRI

[FENG Hao¹,REN Yining¹,LI Guolei¹,LIANG Jianwei²,XING Wei¹]

2024 15 [Abstract]()

[2801-2806] Functional evaluation of bladder wall reconstruction neourethra after radical prostatectomy

[ZHAO Jie^1，2,GUAN Zhenghui^1，2,WANG Jiangping¹]

2024 15 [Abstract]()

[2807-2812] The prognostic value of peripheral blood and urinary routine inflammatory markers in patients with advanced urothelial carcinoma treated with PD-1 inhibitors

[HAO Chao，AI Haitao，ZHONG Huaming，XU Zhihao，HUANG Ji，TU Xinhua]

2024 15 [Abstract]()

[2813-2819] Expression and clinical significance of SARI and PI3K/AKT pathway molecules in bone marrow of AML patients

[WU Wei^1,2，LIN Yazhen^1,3，ZHENG Zhiyuan^1,4，LIN Yanfeng^1,2，LIN Donghong^1,2，XUE Yan^1,2]

2024 15 [Abstract]()

[2820-2825] Effect of neoadjuvant chemotherapy on perioperative neurocognitive disorders in patients with malignant tumors

[QIAO Limei,CHEN Cheng,WANG Zhonghui,XIA Liang,LIU Jianyun,WANG Xiaoyan]

2024 15 [Abstract]()

[2826-2832] Comparative analysis of contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging of mixed hepatocellular carcinoma

[CHEN Jianan¹,ZHU Yuli²,CHEN Yanling³,BAO Jingwen⁴,XUE Zhixia¹]

2024 15 [Abstract]()

[2832-2838] Relationship between extracellular volume fraction and clinicopathological characteristics for colorectal cancer based on spectral CT

[CHENG Qinghong¹,WU Ruixiang¹,WANG Jin²,CAO Feng³,SHENG Mao¹]

2024 15 [Abstract]()

[2839-2844] Building a machine learning model based on SHAP interpretable analysis and MRI imageology to predict the efficacy of neoadjuvant chemotherapy for breast cancer

[ZHAO Ling¹,CHEN Zhengguo¹,LUO Rui¹,YIN Longzhou¹,ZHOU Li¹,HUANG Yao²]

2024 15 [Abstract]()

[2845-2851] Effect of computational grid size on the validation rate of brain metastases

[SUN Bin，ZHONG Siyao，NAN Xianxiu，XU Cheng，GAO Yuyan]

2024 15 [Abstract]()

[2851-2856] Effect of docetaxel combined with carboplatin preoperative neoadjuvant chemotherapy on short-term efficacy and peripheral blood T lymphocyte subsets in patients with locally advanced cervical cancer

[LI Wenjuan¹,GUO Xue²,CHENG Xin¹,QIN Shuang¹,SHANG Xianping³]

2024 15 [Abstract]()

[2857-2865] The survival impact of pelvic lymph node metastasis on early cervical cancer patients using propensity score matching analysis

[HUANG Fengxian¹，GAO Hui¹，CHEN Qingfen²，CAO Ximing¹，ZHAO Shuhong¹]

2024 15 [Abstract]()

[2865-2871] Research progress on the biological mechanism of immunotherapy resistance in renal cell carcinoma

[ZHU Lugang,LIU Jianjun]

2024 15 [Abstract]()

[2872-2881] The relationship between bacteria and tumors

[CHEN Rucai，XIONG Zaikun，ZHAO Caibing，WANG Pengfei]

2024 15 [Abstract]()

[2882-2891] Research progress on non-coding RNA in the occurrence and development of gynecological tumors based on Warburg effect

[XIE Yingying^1,2，LI Dongdong¹，ZHANG Xiaoqing³，MA Chunzheng¹，HU Yiyang^1,2，ZHAO Ningning^1,2，ZHANG Juan^1,2]

2024 15 [Abstract]()

[2892-2897] Research progress of SLC14A1 in the diagnosis and treatment of urological tumors

[LIU Xizhong,SHI Hongjin,FU Shi,ZHANG Yawei,LI Hongqiong,WANG Zhengyan,WANG Jiansong,WANG Haifeng]

2024 15 [Abstract]()

[2897-2902] Research progress of NUPR1 in tumor development

[WANG Jing,LU Yiping,SUN Zhengrong]

2024 15 [Abstract]()

[2903-2909] Advance in the study of HDAC inhibitor Chidamide in hematologic malignancies

[ZHANG Xiaoqian¹，WANG Yu²，LYU Chengfang¹]

2024 15 [Abstract]()

[2909-2914] Progression on relationship between tumor microenvironment and HER2 targeted drug resistance in breast cancer

[ZHU Jiayu，ZHANG Qingyuan]

2024 15 [Abstract]()

[2915-2920] Application progress of circulating tumor DNA in early diagnosis of gastric cancer and colorectal cancer

[SHAN Yifan,DAI Yiyang]

2024 15 [Abstract]()

SITEMAP